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aAdvanced Diagnostic and Interventional Radiology Research Center, Medical Imaging Center, Imam Hospital, Tehran University of Medical Sciences,
Tehran, Iran
bGastrointestinal and Liver Diseases Research Center, Imam Hospital, Tehran University of Medical Sciences, Tehran, IranAbstractObjective: To investigate the performance of different b values and regions of interest (ROI) for diagnosing liver fibrosis in patients with
chronic viral hepatitis by using diffusion-weighted (DW) magnetic resonance imaging (MRI).
Methods: Eleven healthy participants and 33 patients with viral hepatitis B or C were enrolled. The stage of liver fibrosis and the grade of
necroinflammation were determined by using a histologic activity index. Single-shot spin-echo echo-planar DW-MRI was performed in all
participants at b values of 0-500, 0-700, and 0-1000 s/mm2 by using 2 circular small and large ROIs of 100 and 200 mm2. To evaluate the
performance of different b values for determining cirrhosis, the receiver-operating characteristic curves were depicted, and the areas under the
curves were compared.
Results: The average values of apparent diffusion coefficients significantly decreased with increasing stage or grade categories at all the 3
b values and for both small and large ROIs. The performance at b ¼ 500 s/mm2 was significantly better than b ¼ 1000 s/mm2 for determining
cirrhosis or bridging fibrosis. The cut point of 153.4 for apparent diffusion coefficient (105 mm2/s) at b ¼ 500 s/mm2 could determine
cirrhosis or bridging fibrosis with a sensitivity of 96% and specificity of 82%. No difference was found between the average apparent
diffusion coefficient values of large or small ROIs. Also, there was no difference in performance of large or small ROIs in the diagnosis of
liver fibrosis.
Conclusions: This study provided beneficial data for clinical utilisation of DW-MRI in diagnosing liver fibrosis: b ¼ 500 s/mm2 is better in
performance than b ¼ 1000 s/mm2, and a small ROI of 100 mm2 is sufficient for determining cirrhosis or bridging fibrosis.ResumeObjectif : Etudier le rendement de differentes valeurs b et regions d’intere^t (ROI) pour diagnostiquer la fibrose du foie chez des patients
atteints de l’hepatite virale chronique au moyen d’imagerie de diffusion par resonance magnetique (IRM).
Methodes : L’etude portait sur 11 participants en sante et 33 patients atteints de l’hepatite virale B ou C. Le stage de la fibrose du foie et le
degre d’inflammation hepatique ont ete determines au moyen d’un indice d’activite histologique. Des cliches ponderes d’IRM de diffusion
ont ete effectues par sequence d’echo de spin d’imagerie echoplanaire chez tous les participants ayant des valeurs b de 0 a 500, de 0 a 700 et
de 0 a 1 000 s/mm2 sur deux regions d’intere^t circulaires, soit une petite et une grande, respectivement de 100 et de 200 mm2. Pour evaluer le
rendement de differentes valeurs b afin de determiner la cirrhose, les fonctions d’efficacite du recepteur ont ete illustrees et les regions sous
les courbes ont ete comparees.
Resultats : Les valeurs moyennes des coefficients de diffusion apparents affichaient une baisse importante lorsque les categories de stade ou
de degre des trois valeurs b augmentaient, et ce, tant pour les petites et que les grandes regions d’intere^t. Afin de determiner la cirrhose ou la* Address for correspondence: Hadi Rokni-Yazdi, MD, Advanced Diag-
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305Diffusion-weighted imaging in liver fibrosis / Canadian Association of Radiologists Journal 63 (2012) 304e311fibrose en pont, le rendement ou b ¼ 500 s/mm2 etait de loin superieur a celui ou b ¼ 1 000 s/mm2. Le point de coupure de 153,4 pour le
coefficient de diffusion apparent (10e5 mm2/s) ou b ¼ 500 s/mm2 peut determiner la cirrhose ou la fibrose en pont avec une sensibilite de
96 % et une specificite de 82 %. Aucune difference n’a ete relevee entre les valeurs moyennes du coefficient de diffusion apparent des petites
et des grandes regions d’intere^t. En outre, les deux types de regions d’intere^t n’affichaient pas de difference de rendement quant au diagnostic
de la fibrose hepatique.
Conclusions : Cette etude a produit des donnees tres utiles pour l’utilisation clinique l’IRM de diffusion en vue de diagnostiquer la fibrose du
foie : b ¼ 500 s/mm2 produit un meilleur rendement que b ¼ 1 000 s/mm2, et une petite region d’intere^t de 100 mm2 suffit pour determiner
la cirrhose ou la fibrose en pont.
 2012 Canadian Association of Radiologists. All rights reserved.
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liver cirrhosis in patients with chronic viral hepatitis [1].
Because the severity of fibrosis affects the patient’s
management, outcome, and the need to antiviral treatment,
the exact identification of the stage of liver fibrosis is
of utmost importance [2]. Percutaneous liver biopsy has
traditionally been used as the criterion standard method for
evaluating the severity of fibrosis in patients with chronic
liver disease [3]. However, it is an invasive procedure with
poor patient acceptance, a rate of 0.3% for major compli-
cations, and the possibility of sampling errors [4,5]. There-
fore, numerous efforts have been made to use noninvasive
methods in quantification of liver fibrosis [6]. Transient
elastography or biochemical scores, including aspartate
aminotransferase to platelet ratio index or a FibroTest, have
all been proposed for this goal, but their role in clinical
practice is currently being investigated [7,8].
Diffusion-weighted (DW) magnetic resonance imaging
(MRI) is an emerging tool in evaluating the stage of fibrosis
[9e11]. This technique quantifies the combined effects of
microcirculation of blood (perfusion) and molecular Brow-
nian motion of water (diffusion) in liver parenchyma by
means of apparent diffusion coefficients (ADC) [12]. Several
researchers have mentioned that ADC values are signifi-
cantly lower in patients with cirrhosis, with this reasonable
explanation that fibrotic changes in liver parenchyma would
restrict the motion of water molecules [13,14]. Nonetheless,
disparities in the technical settings, the amount of b values
(the combination effect of strength and duration of the
gradients taken into account throughout the spin-echo
evolution intervals) and the patient populations have led to
inconsistent findings. Previous studies have used various
ranges of b values for studying liver fibrosis [13e15].
Despite this, less evidence is available about the comparative
performance of these b values in determining liver fibrosis.
Also, previous studies have investigated liver fibrosis in
different regions of interest (ROI), ranging from 50-173 mm2
[11,16,17]. However, the influence of choosing small or large
ROIs on determining liver fibrosis has not been addressed
before. The aim of the present study was to investigate the
performance of 3 different b values (0-500, 0-700, and
0-1000 s/mm2) and 2 different ROIs (100 and 200 mm2) for
a diagnosis of liver fibrosis in patients with chronic viral
hepatitis by using DW-MRI.MethodsParticipantsA total of 11 healthy subjects and 33 patients with viral
hepatitis B (n ¼ 17) or C (n ¼ 16) were enrolled in this study.
The patients were consecutively and prospectively enrolled
from those who were admitted to the gastroenterology ward
of a large university general hospital. Healthy volunteers
were recruited from the healthy participants who regularly
visited at general clinic of the same hospital. The mean age
( standard error of the mean [SEM]) of healthy controls (2
women [18%]) and of patients (4 women [12%]) was 38.87
 3.84 and 37.93  2.29 years, respectively. The research
was carried out according to the principles of the Declaration
of Helsinki. The local ethics review committee of our
university approved the study protocol. All the participants
gave written informed consent before sampling.
To minimize the probable effect of steatosis [18], liver
ultrasonography (Sonoline Antares; Siemens, Erlangen,
Germany) was performed by a single experienced radiologist,
and the participants with evidence of fatty liver [19] were
excluded. None of the participants were alcohol users, and
none of them had a history or clinical evidence of liver
diseases other than chronic viral hepatitis. The diagnosis of
hepatitis B and C infection was based on consistent clinical
findings, serologic markers, hepatitis B virus DNA, and
hepatitis C virus RNAmeasurements by the polymerase chain
reaction method and histologic examinations (liver biopsy).
None of the patients were under treatment for hepatitis B or C
infection. Antibodies to hepatitis C virus, hepatitis B surface
antigen, hepatitis B surface antibody, hepatitis B core anti-
body, hepatitis B e antigen, and hepatitis B e antibody were
measured by using commercially available enzyme-linked
immunosorbent assay kits (DRG Diagnostics GmbH, Mar-
burg, Germany). All the healthy participants had normal liver
transaminases and negative markers of hepatitis B and C
infection. Liver biopsy was performed in the right liver lobe in
all the patients (n ¼ 33) as a part of their routine clinical care,
and the samples were reported by one experienced patholo-
gist. The stage of liver fibrosis (0-6, none; portal fibrosis,
some; portal fibrosis, most; bridging fibrosis, few; bridging
fibrosis, many; incomplete cirrhosis; and cirrhosis), and the
grade of necroinflammatory activity (0-18) was determined by
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the grade of necroinflammatory activity is determined based
on the degree of periportal necrosis, including piecemeal
necrosis and/or bridging necrosis, the degree of bridging
necrosis, the degree of hepatocyte degeneration and focal
necrosis within the lobule, and the degree of portal inflam-
mation. The patients, who were consecutively referred from
the gastroenterology ward, were enrolled in 1 of the 3 cate-
gories of liver fibrosis (portal fibrosis, stage 1 or 2; bridging
fibrosis, stage 3 or 4; and cirrhosis, stage 5 or 6), based on the
predetermined sample size (n ¼ 11 in each category).Diffusion-Weighted ImagingMRI measurements were performed on a GE Signa 1.5 T
(GE Medical Systems, Milwaukee, WI). DW-MRI data were
acquired before biopsy (4-14 days; in 4 of the patients) or at
least 1 month after biopsy (30-60 days; in 29 of the patients) to
avoid the potential effect of the procedure on the images. By
performing a routine respiratory-gated axial fast spin-echo
T2-weighted sequence of whole liver in all the participants,
we excluded patients with any focal liver lesions (n¼ 2) before
the DW imaging (DWI). A body coil was used for all experi-
ments, with participants in the supine position. Six slices in the
middle portion of the liver (with a localizer in the coronal plane
for slice placement) were obtained (with 6-mm thickness and
spacing of 2 mm). The participants were asked to hold their
breath during each DW-MRI acquisition, which was less than
20 seconds (the acquisition time was between 16 and 17
seconds). Also a technician was monitoring the respiratory
movements of the patients during image acquisitions by
looking at the monitor for respiratory wave pattern changes; in
case of any accidental or unintentional breathing during
examination, a repeated examination was requested. Three
breath-hold acquisitions were performed in the same liver
locations at b values of 0-500, 0-700, and 0-1000 s/mm2, with
tridirectional diffusion gradients. Acquisition parameters of
DW-MRI were the following: single-shot spin-echo
echo-planar DW-MRI, repetition time ¼ 1000, echo time ¼
minimum, matrix size ¼ 128  128, field of view ¼ 40,
number of excitation ¼ 4, band widths ¼ 62 kHz. Analysis of
DW-MRI data were performed with the GE FUNCTOOL
software (GE Medical Systems) to obtain ADC maps at each
b value (500, 700, and 1000 s/mm2). We selected the best 3
slices in the right lobe of the liver, far from the diaphragm,
vessels, and ducts, mainly at segments 5 and 6. Two experi-
enced observers placedROIs in themost appropriate locations;
far from the diaphragm, vessels, and ducts, in each selected
slice. Two different sizes of circular ROIs (small, 100 mm2;
and large, 200mm2)were applied in each slice. For either large
or small ROIs, the average of the 3 mean ADC numbers
of the 3 selected slices was considered as the ADC value
of participant. The axial echo-planar diffusion-weighted
images of a liver at b values 500 and 1000 s/mm2 are demon-
strated in Figure 1. Although the quality of the images some-
what decreases with an increase in b value, the ADC map is
more homogeneous and easier to use on higher b-value images.Statistical AnalysisStatistical analysis was performed by SPSS software
(version 18.0; SPSS Inc, Chicago, IL). The required sample
size to detect a significant association at a ¼ .05 and with
a power of 80%was estimated to be 11 in each 2 neighbouring
groups of HAI of liver fibrosis (portal fibrosis, stage 1 or 2;
bridging fibrosis, stage 3 or 4; and cirrhosis, stage 5 or 6).
Continuous variables are expressed as mean  SEM. The
value of ADC was compared among different stage or grade
groups by using analysis of variance and the post hoc Tukey
test. The method of general linear modelling was used to
compare the adjusted values of ADC among different grade or
stage categories. The level of association between the grade or
stage and other variables was measured by using Spearman
rank order correlation coefficients. To compare the perfor-
mance of different b values for determining patients with
cirrhosis, the receiver-operating characteristic (ROC) curves
were depicted and the area under the curves (AUC) were
compared by using STATA software (version 9.0; StataCorp,
College Station, TX). The shortest distance value from the
point (0,1) ([1e sensitivity]2þ [1e specificity]2) on the ROC
curve [21] was determined as the optimal cut point of ADC for
determining cirrhosis or bridging fibrosis in different b values.
P < .05 was considered statistically significant.
Results
No difference was found in age and sex ratio between
healthy controls and patients (mean [ SEM] age, 38.87 
3.84 years vs 37.93  2.29 years; and women/men, 2/9 vs
4/29, respectively) and among different stages of liver fibrosis.
The mean (SEM) of stage of liver fibrosis and grade of nec-
roinflammation in the patients group were 3.45  0.34 and
8.75  0.58, respectively.The ADC Values in Different Stages and Grade
Categories by Using Different b Values and ROIsThe mean value of ADC (105 mm2/s) in different stage
and grade categories according to different b values (s/mm2)
are presented in Table 1. No significant difference was found
in the average ADC values of participants between the large
and small ROIs at all 3 b values. The average ADC values
significantly decreased from the control group to the patients
with higher grades or stages of cirrhosis in both large and
small ROIs and in all the 3 different b values. When
considering the data of different b values and different ROIs
together, the percentage of reduction in the average ADC
value (in comparison with the control group) was approxi-
mately 10% in patients with bridging fibrosis and approxi-
mately 15% in patients with cirrhosis. Although higher-grade
categories were significantly associated with lower ADC
values, this association completely disappeared after adjust-
ment for the stage of fibrosis (P >.05) in all different b values
and for both small and large ROIs. However, the association
between stage categories and ADC values was independent
Figure 1. Axial echo-planar diffusion-weighted images (DWIs) of the liver at b values of 500 and 1000 s/mm2, and their corresponding apparent diffusion
coefficients (ADC) maps in a 53-year-old man with chronic hepatitis B (stage I on biopsy): (A) DWI at b ¼ 500; (B) the corresponding ADC map (ACD value
with small regions of interest [ROI], 1.66 mm2/s; ACD value with large ROI, 1.62 mm2/s); (C) DWI at b ¼ 1000; and (D) the corresponding ADC map (ACD
value with small ROI, 1.13 mm2/s; ACD value with a large ROI, 1.17 mm2/s).
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of inflammation.The Association Between ADC Values and Stage or
Grade ScoresThe grade and stage of fibrosis were significantly corre-
lated (r¼ 0.604, P< .001). The association between the ADC
values and the stage of fibrosis and grade of inflammation in
patients are presented in Table 2. These associations were
generally stronger in the lowest b value (500 s/mm2). For
example, no association was found between grade and ADC in
the b value of 1000. The associations between stages of liver
fibrosis and ADC values were independent of grade at
different b values and ROIs; however, the associations
between the grades and ADC values lost their significance
after adjustment for stage of fibrosis.Optimal Cut Points for Determining Cirrhosis and
Bridging FibrosisROC analysis showed that there was a significantly
(P < .05) better performance for b ¼ 500 in comparison with
b ¼ 1000 for determining stage  5 (cirrhosis: mean [
SEM] AUC, 0.86  0.06 vs 0.72  0.09, respectively) and
stage  3 (cirrhosis or bridging fibrosis: mean [ SEM]
AUC, 0.92  0.041 vs 0.79  0.07, respectively) by using
small or large ROIs. No difference was found between the
performances of large or small ROIs in the diagnosis of liverfibrosis at each of the 3 b values. Because there were almost
similar results for small or large ROIs, we only presented our
results for small ROIs (Figure 2). The optimal cut point of
ADC values for determining stage 5 (cirrhosis) and stage
3 (cirrhosis or bridging fibrosis) in different b values, by
using small ROIs, are presented in Table 3.
Discussion
Histopathologic feature is an important factor to assess
the patient’s prognosis and the need for antiviral therapy in
chronic viral hepatitis [22]. Percutaneous liver biopsy is the
criterion standard method to evaluate the stage of fibrosis and
grade of necroinflammatory changes in these patients [23].
Nonetheless, liver biopsy is not free of risk and is associated
with the need for hospitalization and patient discomfort [4].
Conventional MRI did not show satisfactory results in the
evaluation of disease activity in chronic hepatitis [24].
Numerous efforts have been made to describe magnetic
resonance (MR) diagnostic criteria to quantify the liver
pathologic changes [25]. For example, the caudate-to-right
lobe ratio of more than 0.90, measured on gadolinium-
enhanced images, showed sensitivity and specificity of
71.7% and 77.4%, respectively, in diagnosing patients with
cirrhosis [25]. Another example is MR elastography, which
is a new technique for staging of liver fibrosis [26]. It is
reported that MR elastography is superior to biochemical
testing with aspartate aminotransferasesetoeplatelet ratio
index [27]. In a study by Huwart et al [27], it was shown that
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discriminating different stages of hepatic fibrosis in chronic
viral hepatitis. The areas under the ROC curve for elasticity
and viscosity were 0.997 and 0.962, respectively, at
METAVIR fibrosis scores greater than or equal to F3 [27].
DW-MRI takes into account the microcirculation of blood
(perfusion) and molecular Brownian motion of water
(diffusion) in liver parenchyma [28]. Muller et al [29]
measured a mean ( SEM) ADC value of 0.9-1.2  103
mm2/s in patients with cirrhosis vs 1.39  0.16  103 mm2/
s in healthy controls by using a maximal b value of 454 mm2/
s. Girometti et al [11] reported the mean ( SEM) ADC of
1.11  0.16 103 mm2/s in patients with cirrhotic livers
compared with a mean ADC of 1.54  0.12  103 mm2/s in
controls by using a maximal b value of 800 mm2/s [11]. The
discrepancies in results arise from several factors, including
patient populations and imaging settings such as echo time
values, but the most influencing factor is indeed the adopted
b values. Previous studies have used a wide range of
maximum b values, from 55-1200 s/mm2 [30,31]. In fact, the
b value reflects the effectiveness of the diffusion-probing
gradients, which are applied in a diffusion-weighted
sequence. As a rule, higher b values correlate with lower
ADCs, which are underestimated due to the gradient-
enhanced signal degradation that eliminates fast-diffusion
contributions. In contrast, lower b values result in higher
ADCs, which are overestimated as a consequence of signal
contribution from other intravoxel incoherent motions [10].
Some researchers recommend using higher b values to
approach the ADC to the true diffusion coefficient, based
upon the assumption that, at lower b values, the effect of
perfusion contributes to the ADCs of abdominal organs,
including liver parenchyma [32]. However, the other
researchers argue that lower maximum b values would
improve the signal-to-noise ratio in the liver [33]. Girometti
et al [16] conducted a study to evaluate liver fibrosis by using
2 consecutive diffusion-weighted experiments with
2 different maximal b values of 400 and 800 s/mm2. They
found a lower mean ( SEM) ADC in cirrhotic livers vs
noncirrhotic ones, expected by using either the first (b ¼ 400
s/mm2; 1.14  0.20 103 mm2 /s vs 1.54  0.12 103
mm2/s) or second sequence (b ¼ 800 s/mm2; 0.91  0.18
103 mm2/s vs 1.04  0.18 103 mm2/s). However, ROC
analysis showed that the second sequence had significantly
lower accuracy, sensitivity, specificity, and positive and
negative predictive values compared with the first sequence
in terms of quantifying liver fibrosis. Finally, they suggested
that high b values would be less reliable in discrimination
between normal and fibrotic livers [16]. In another study, the
AUCs of 0.913, 0.825, and 0.794 was obtained for deter-
mining HAI of 3 or higher by using maximal b values of 500,
1000, and 200 s/mm2, respectively. These results show
a better performance for b ¼ 500 [34]. However, in
a different study, which compared 5 different b values (100,
300, 500, 800, and 1000 s/mm2), the best negative correlation
between ADC value and stage of fibrosis was obtained at the
b value of 800 mm2/s [35]. In the present study, in line with
Table 2
The association between apparent diffusion coefficients (105 mm2/s)
values and stages of fibrosis and grade of inflammation in different b values
and small or large regions of interest
b Value (s/mm2)a
500 700 1000
Small Large Small Large Small Large
Stage e0.618z e0.599z e0.588z e0.566y e0.492y e0.510y
Grade e0.521y e0.486y e0.443y e0.471y e0.273* e0.340*
* P< .05.
y P < .01.
z P < .001.
a Small (100 mm2) or large (200 mm2) regions of interest.
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would lead to a worse performance in determining liver
fibrosis. Also, the association between the ADC values and
the stage of fibrosis was stronger in the b value of 500 than of
1000 s/mm2.
Several researchers have described a decreased level of
perfusion in fibrotic livers [36,37]. Annet et al [38], in a rat
study, compared the ADC of liver parenchyma in rats that
had liver fibrosis with normal rats. As expected, they found
that ADC was lower in fibrotic livers compared with normal
livers. But, interestingly, they could not observe this
phenomenon when comparing the ADC on dead animals,
which do not have the effect of perfusion in their liver [38].
Taken together, it is suggested that ADC is probably, to
a greater extent, a function of decreased perfusion rather than
restricted Brownian motion of water molecules due to
collagen deposition in extracellular environment.
It is notable that most of previous studies compared
DW-MRI with a simple 4-stage and 4-grade scoring system,Figure 2. (A) Receiver-operating characteristic curves for performance of appa
(cirrhosis). (B) Stage  3 (cirrhosis or bridging fibrosis) in different b values (sBatts-Ludwig classification. Although this classification is
simple and easily reproducible, it lacks the clarity of verbal
description, which can lead to confusion for less-experienced
clinicians. In this study, we used HAI as our classification,
which is a more elaborative system for clinical and patho-
logic evaluations due to the abundance of descriptive details
[23]. In a study that used HAI, the optimal ADC cut point of
1.31  103 mm2/s, at maximal b ¼ 400 s/mm2, showed
sensitivity and specificity of 92.9% and 100%, respectively,
in discrimination of liver cirrhosis [11]. In the present study,
the optimal cut point of 153.4 for ADC (105 mm2/s)
at a b value of 500 s/mm2 could determine cirrhosis or
bridging fibrosis with a sensitivity of 96% and specificity
of 82%.
Accurate quantification of liver fibrosis in patients with
chronic hepatitis is mandatory to avoid adverse effects of
unnecessary antiviral treatment or a lack of necessary treat-
ment [23]. Therefore, researchers have mainly focused their
studies on finding a correlation between the results of their
noninvasive methods and the stages of liver fibrosis. In this
study, we observed a significant and independent correlation
between the mean ADC and the stage of liver fibrosis. The
association between the grade of necroinflammatory activity
and ADC was not, however, independent, and totally
disappeared after adjustment for stage of fibrosis. Koinuma
et al [10], by using a maximum b value of 128 s/mm2, in line
with our findings, showed a significant negative correlation
between ADC and stage of fibrosis but could not show any
correlation between ADC and the grade of necroin-
flammatory changes. In another study, Taouli et al [13] also
found a negative correlation between ADC and the stage of
fibrosis, but a weaker negative correlation also was found
between ADC and grade of necroinflammation.rent diffusion coefficients values (105 mm2/s) in determining stage  5
/mm2) by using small regions of interest.
Table 3
The performance of ADC (105 mm2/s) for determining cirrhosis and
bridging fibrosis in different b values (s/mm2), when using small ROIs
b Values AUC  SEM
ADC
cut point
%
Sensitivity
%
Specificity PLR NLR
Cirrhosis (stage  5)
500 0.86  0.06z 147.5 74 82 4.1 0.3
700 0.81  0.07y 129.5 72 73 2.7 0.4
1000 0.72  0.09* 102.2 63 62 1.6 0.6
Cirrhosis or bridging fibrosis (stage  3)
500 0.92  0.04z 153.4 96 82 5.3 0.05
700 0.88  0.05z 134.2 89 72 3.2 0.2
1000 0.79  0.07z 107.8 72 3.0 0.2
ADC ¼ apparent diffusion coefficient; AUC ¼ area under the curve; NLR ¼
negative likelihood ratio; PLR ¼ positive likelihood ratio; ROI ¼ region of
interest; SEM ¼ standard error of the mean.
* P< .05.
y P < .01.
z P < .001.
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from 0.5-1.73 cm2 for calculating the ADC [11,16e18].
However, no evidence is available to identify what extent of
ROI is sufficient to discriminate liver fibrosis. In this study,
we did not find any significant difference in performance of
a large or small ROI in terms of identifying liver fibrosis. In
fact, our study showed that an ROI of 1 cm2 would be
sufficient for determining liver fibrosis.
This study has some limitations. We should note that we
could perform a more in-depth analysis in each of the
6 stages of liver fibrosis if we had a larger sample size.
Because of the limited numbers of available patients, we
assigned each 2 neighbouring stages into one category.
Nonetheless, this classification is clinically relevant; for
example, the presence of bridging fibrosis (stage 3 or higher
of HAI) is significant for starting the antiviral treatment, and
stage 5 and 6 shows almost untreatable cirrhosis [23].
Besides, in this study, we used 3 maximal b values, and we
showed a decreasing trend for performance of determining
liver fibrosis when using higher vs lower b values. To
determine the most appropriate b value in discriminating
stages of liver fibrosis, we encourage future studies to also
compare the performance of b ¼ 500, with lower maximum
b values. A major limitation of the study is the use of single
b values in calculating the ADC values. Modern MR scan-
ners can simultaneously obtain multiple b values during
a single DWI acquisition, and, because ADC is calculated
from the slope of a diffusion signal plotted against b value,
the ADC becomes much more accurate when using multiple
b values. Therefore, we encourage future studies to use ADC
values obtained from multiple b values. We should mention
that our results are valid with our protocol. In fact, there are
many variables in the type of DW-MRI sequences that would
likely alter the results, and larger trials that involve different
MR and different sequences would be necessary to validate
these results. In this study, we only enrolled patients with
chronic viral hepatitis only. Although, as an advantage,
this can lead to a more homogeneous sample of patients for
this study, it could be interesting to have these data inpatients with other causes of liver fibrosis. In addition, as we
know, patients with chronic viral hepatitis may need several
liver biopsies through their follow-up and treatment, so
follow-up DW-MRI in an individual patient and evaluating
the correlation of ADC values with the changes in stage of
liver fibrosis may show promising results. The time frame
for this study prevented us from including the follow-up data
of patients; we will go through this assessment later, if
possible. As an advantage, in our sample, there was no
difference in the age of healthy controls and patients in
different stages of liver fibrosis. Because some age-related
changes may be observed in liver parenchyma of older
subjects, this point has been regarded as a drawback of some
studies, which could not adjust for this potential confounder
[11,16].
In summary, this study showed that using either a small ROI
of 100 mm2 or a large ROI of 200 mm2 would not result in
a significant difference in performance of DW-MRI in
diagnosing liver fibrosis. Also, our results showed that
a b¼ 500 s/mm2 is better in performance than b¼ 1000 s/mm2
for determining cirrhosis or bridging fibrosis. This study
provided beneficial data for choosing the more appropriate
b values and the sufficient ROIs for clinical utilisation of
DW-MRI in diagnosis of liver fibrosis.
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